What is the appropriate dosing regimen for combining regular (short‑acting) insulin with NPH (intermediate‑acting) insulin in an adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Regular Insulin and NPH Insulin Combination Regimen

When combining regular (short-acting) insulin with NPH (intermediate-acting) insulin in adults with type 2 diabetes, initiate with a twice-daily split-mixed regimen: give 2/3 of the total daily dose before breakfast and 1/3 before dinner, with regular insulin drawn into the syringe first when mixing. 1

Initial Dosing Strategy

Starting NPH Insulin

  • Begin with 10 units per day OR 0.1-0.2 units/kg per day when initiating basal NPH insulin alone 1
  • Titrate by increasing 2 units every 3 days to reach fasting plasma glucose goal without hypoglycemia 1
  • For hypoglycemia without clear cause, lower the dose by 10-20% 1

Adding Prandial Regular Insulin to NPH

When A1C remains above goal on bedtime NPH alone, you have two main approaches:

Option 1: Convert to Twice-Daily NPH Plan 1

  • Calculate total dose as 80% of current bedtime NPH dose 1
  • Distribute as 2/3 before breakfast, 1/3 before dinner 1
  • Add 4 units of regular insulin to each injection OR 10% of the reduced NPH dose 1

Option 2: Add Prandial Insulin to Bedtime NPH 1

  • Start with 4 units per day OR 10% of basal insulin dose with the largest meal 1
  • Regular insulin can be dosed individually or mixed with NPH as appropriate 1
  • Increase dose by 1-2 units or 10-15% based on postprandial glucose 1

Mixing Technique

Critical mixing order to prevent dosing errors:

  • Always draw regular (short-acting) insulin into the syringe FIRST, then NPH 2
  • This prevents contamination of the regular insulin vial with NPH 2
  • Use only U-100 insulin syringes to avoid dosage errors 2
  • The mixture should be injected within 15 minutes before a meal when rapid control is needed 1

Titration and Monitoring

Dose Adjustments

  • Increase by 1-2 units or 10-15% of insulin dose based on glucose patterns 1
  • Titrate each component (NPH and regular) separately based on individualized needs 1
  • If A1C <8% (<64 mmol/mol), consider lowering basal dose by 4 units per day or 10% 1

Hypoglycemia Management

  • Reduce corresponding dose by 10-20% if hypoglycemia occurs without clear cause 1
  • Consider switching from evening NPH to a basal analog if recurrent hypoglycemia develops 1

Timing and Administration

Injection Timing

  • Regular insulin should be given approximately 30 minutes before meals 2
  • NPH in twice-daily regimens: morning dose before breakfast, evening dose before dinner 1
  • Rotate injection sites within the same region (abdominal wall provides fastest absorption) 2

Storage Considerations

  • Refrigerate unopened vials at 2-8°C (36-46°F) 2
  • In-use vials can be kept unrefrigerated below 30°C (86°F) for up to 31 days 2
  • Never use if insulin has become viscous, cloudy (for regular), or has changed color 2

Progression to Full Basal-Bolus

If A1C remains above goal on twice-daily mixed insulin:

Proceed to full basal-bolus plan 1

  • Continue NPH as basal component (80% of previous NPH dose) 1
  • Add regular insulin with each meal (4 units or 10% of reduced NPH dose per injection) 1
  • Titrate each component independently based on fasting and postprandial glucose patterns 1

Important Caveats

When to Avoid This Regimen

  • Do not mix insulin glargine with any other insulin due to low pH of its diluent 1
  • Consider switching to basal analogs if patient frequently forgets evening NPH doses 1
  • Avoid mixing phosphate-buffered insulins (NPH) with lente insulins 1

Special Considerations

  • Premixed 70/30 formulations (70% NPH, 30% regular) can substitute for self-mixed regimens when the ratio matches patient needs 1
  • This reduces injection burden and mixing errors 1
  • Weight gain is more pronounced with daytime regular insulin (mean 3.4 kg) compared to bedtime NPH alone (1.9 kg) 3
  • Consider GLP-1 receptor agonists in combination if cardiovascular disease is present or to mitigate weight gain 1

Monitoring Requirements

  • Measure blood glucose four times daily (fasting and pre-meals) to guide titration 4
  • Target fasting plasma glucose typically 80-130 mg/dL 1
  • Assess adequacy at every visit for signs of overbasalization (dose >0.5 units/kg/day, persistent hyperglycemia despite escalation) 1

Related Questions

On a cycled tube feed (TF) providing 116 g of carbohydrate (Cho), the patient receives 18 U of NPH insulin (NPH) and has blood glucose (BG) readings of 208, 286, and 259 mg/dL; what should the new NPH insulin dose be?
A patient taking prednisone 60 mg and NPH insulin 20 units at 8 am with a carbohydrate‑to‑insulin ratio of 1 unit per 10 g has blood glucose 201 mg/dL at noon and 325 mg/dL at 4 pm; how should the NPH dose and carb ratio be adjusted?
How much should the NPH insulin dose be increased for a patient with hyperglycemia on 35 units of NPH insulin and 40 mg of prednisone, with blood glucose spikes to 453 after meals, and what adjustment should be made to the carb ratio of 1 per 10?
How is Mixtard (premixed regular insulin and NPH insulin) administered?
In a 72-year-old obese female with type 2 diabetes, normal renal function, currently off tirzepatide (Mounjaro) after abdominal surgery and receiving continuous total parenteral nutrition containing 180 g dextrose, how many units of insulin should be added to the TPN?
What is the risk of colorectal cancer in a 38-year-old patient with a tubular adenoma containing high-grade dysplasia and no family history of colorectal cancer?
What is the recommended treatment for acute gouty arthritis and long‑term urate‑lowering therapy?
What are the indications for coenzyme Q10 supplementation?
What are the recommended dosing regimens for medications used to treat an acute gout flare and for long‑term urate‑lowering therapy?
What is the recommended management of dilated cardiomyopathy?
What patient and operative data should be collected for a case report on chronic patellar dislocation treated surgically?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.